Tenders Are Invited For Isotopic Reagents – Purchase Of 18F-Fdg Radiopharmaceutical

Isotopic Reagents – Purchase Of 18F-Fdg Radiopharmaceutical. Occasionally Delivery Of 14.8 Gbq - 25.53 Gbq (400-690 Mci) Calibration Quantity Of Licensed Fdg Radiopharmaceutical On Working Days (4-5 Working Days/Week). The Tenderer Specifies The Quantities To Be Ordered For 36 Months As Information, But Does Not Undertake To Use Them In Full. Fdg 400 Mci Activity At The Calibration Time 60 Units Fdg 590 Mci Activity At The Calibration Time 750 Units Fdg 690 Mci Activity At The Calibration Time 60 Units Optional Amount Is 30% Of The Quantities Specified Above. Calibration Time: Between 7:30 And 8:30 (Recommended). Arrival Time: No Earlier Than 45, No Later Than 15 Minutes Before The Calibration Time. It Is The Responsibility Of The Winner To Provide 1 Lead-Shielded Ampoule, Which Is Compatible With The Karl 100 Automatic Radiopharmaceutical Syringe Filling Device And Injection System. The Detailed Public Procurement Technical Description Is Contained In The Public Procurement Documents. The Parties Enter Into The Framework Purchase Agreement For A Fixed Period Of 36 Months, But At Most Until The Framework Sum Is Exhausted. Accordingly, The Total Amount Is The Amount Of The Framework Amount, The Amount Of Which Is Huf 487,680,000 Net For The Basic Quantity And Huf 146,304,000 Net For The Option Quantity. If The Framework Amount Is Not Exhausted During The 36-Month Period Of The Framework Contract, Or If The Tenderer Wishes To Take Advantage Of The Option Of Calling The Option Quantity, The Tenderer May Extend The Duration Of The Contract Once By An Additional Fixed Period Of 12 Months By Notifying The Tenderer With A Unilateral Written Statement At Least 30 Days Before The End Of The 36-Month Fixed Period That It Wishes To Extend The Contract. The 2005 Xcv. Tv. Section 5 (1) The Marketing Authorization Is The Official Decision Authorizing The Use Of The Medicine For Human Medicinal Purposes Issued By The Competent Authority. If This Law Does Not Provide Otherwise, A Drug - With The Exception Of The Magisterial Drug - May Only Be Placed On The Market If It Has Been Authorized By The Pharmaceutical State Administrative Body Or The European Commission On The Basis Of Regulation 726/2004/Ec Of The European Parliament And Council, Regulation 1901/2006/Ec Of The European Parliament And Council Or Regulation 1394/2007/Ec Of The European Parliament And Council. The Evaluation Method Is In Accordance With The Code Of According To § 76, Paragraph (2), Point C), The Best Value For Money.